top of page

Metabolomics: The Future of Personalized Medicine

How can we provide more precise diagnostics, better treatment and faster responses to disease development? The answer may lie in metabolomics – and this was the topic when Oslo University Hospital (OUS) in collaboration with Health2B brought together researchers, clinicians and partners for a professional day in Oslo on September 24.



Spotlight on Norway: Head of the Section for Metabolomics and Lipidomics at OUS Katja Elgstøen highlighted how OUS can take a leadership role in the development of patient-oriented metabolomics. Photo: Natalie Enbusk Jacobsen.
Spotlight on Norway: Head of the Section for Metabolomics and Lipidomics at OUS Katja Elgstøen highlighted how OUS can take a leadership role in the development of patient-oriented metabolomics. Photo: Natalie Enbusk Jacobsen.

Comments


Contact us

bottom of page